A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease.

Turner, R Scott

A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease. [electronic resource] - Neurology Oct 2015 - 1383-91 p. digital

Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.

1526-632X

10.1212/WNL.0000000000002035 doi


Aged
Aged, 80 and over
Alzheimer Disease--blood
Double-Blind Method
Female
Gastrointestinal Diseases--blood
Humans
Male
Middle Aged
Resveratrol
Stilbenes--adverse effects